Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02752737 · ClinicalTrials.gov registry record

Cryo Global Registry

A clinical trial, sponsored by Medtronic Cardiac Ablation Solutions.

Completed
Registry status
5,385
Enrollment target

NCT02752737: Completed study, sponsored by Medtronic Cardiac Ablation Solutions.

NCT02752737 is a clinical trial that has completed, run by Medtronic Cardiac Ablation Solutions. The registered enrollment target is 5,385 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02752737 has completed, sponsored by Medtronic Cardiac Ablation Solutions.

COMPLETED
Registry status
5,385 participants
Enrollment target

Study Summary

Cryo Global Registry a prospective, global, multi-center, observational Post-Market Registry

Primary Outcome

Estimate the 12 month freedom from AF recurrence using the Arctic Front™ Cardiac Cryoablation Catheter System

Trial Details

FieldValue
Enrollment Target 5,385 participants
Start Date 2016-05-02
Est. Completion 2024-11-29

What the finished NCT02752737 record still lists

NCT02752737 is an observational study that tracks outcomes without assigning an intervention. Its 5,385 participants enrollment target places it among the larger protocols in the corpus.

The record links to 0 conditions, and to 0 interventions.

NCT02752737 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02752737 about?

NCT02752737 is a clinical study titled "Cryo Global Registry". Cryo Global Registry a prospective, global, multi-center, observational Post-Market Registry

What is the current status of trial NCT02752737?

This trial is currently completed. The enrollment target is 5,385 participants. The study started on 2016-05-02. Estimated completion is 2024-11-29.

Who is sponsoring clinical trial NCT02752737?

This trial is sponsored by Medtronic Cardiac Ablation Solutions, which has 20 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05722769 · 5,408 participants · NA

    CSTOP Now! Child Sex Trafficking Stops With You

  • NCT05836987 · 5,350 participants · Phase 3

    The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation

  • NCT05373771 · 5,328 participants · NA

    Sickle Cell Improvement: Enhancing Care in the Emergency Department

  • NCT04295486 · 5,478 participants · Phase 2

    Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02752737, the US trial registry maintained by the National Library of Medicine. NCT02752737 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.